As of Jul 02
| +0.09 / +8.11%|
The 1 analysts offering 12-month price forecasts for Bio Path Holdings Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +316.67% increase from the last price of 1.20.
The current consensus among 1 polled investment analysts is to Buy stock in Bio Path Holdings Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.